Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-901-9 | CAS number: 7778-39-4
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 26 to November 11, 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study performed similarly to OECD guideline 401 without any deviation
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Arsenic acid
- EC Number:
- 231-901-9
- EC Name:
- Arsenic acid
- Cas Number:
- 7778-39-4
- Molecular formula:
- H3AsO4
- IUPAC Name:
- arsoric acid
- Details on test material:
- - Name of test material (as cited in study report): Arsenic acid
- Physical state: Clear, green liquid
- Composition of test material, percentage of components: Arsenic acid 75% w/w
- Analytical purity: sponsor assumes responsibility for purity and stability determination
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Crl:CD-1 (ICR) BR strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Portage, MI, USA
- Age at study initiation: Young adult (ca. 8 weeks)
- Weight at study initiation: 18-25 g
- Fasting period before study: 4-5 hours
- Housing: Housed in groups of 5/sex in cages
- Diet (e.g. ad libitum): Purina Rodent Chow; ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-23 °C
- Humidity (%): 53-64%
- Photoperiod (hours dark / hours light): 12 hours dark / 12 hours light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg bw
DOSAGE PREPARATION: The test material was mixed with distilled water to form a uniform suspension at a specific concentration according to dose level.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Dose was selected based on a range-finding study conducted on 1 mouse/sex/dose at 4 dose levels. - Doses:
- 75, 100 and 200 mg/kg bw
- No. of animals per sex per dose:
- 5 animals/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Each animal was observed for clinical signs and mortality at 1, 2.5 and 4 hours after dosing and daily thereafter for 14 days for clinical signs and twice daily for mortality. Individual bodyweights were recorded on Days 0 (prior to dosing), 7 and 14 or at death.
- Necropsy of survivors performed: Yes - Statistics:
- LD50 was estimated using a modified Behrens-Reed-Muench cumulant method (Thakur AK and Fazio WL, 1981).
Results and discussion
- Preliminary study:
- No data
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 141.4 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 98.8 - <= 202.3
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 160.4 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 107.1 - <= 240.3
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 149.6 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 114.4 - <= 195.5
- Mortality:
- - At 75 mg/kg bw: No deaths
- At 100 mg/kg bw: 1/5 male and 1/5 female died on Day 1
- At 200 mg/kg bw: 4/5 males and 2/5 females died on Day 1; one female died on Day 3 - Clinical signs:
- other: Clinical signs noted were diarrhoea, hypoactivity, ataxia and tremors. All signs in surviving animals resolved completely by Day 4.
- Gross pathology:
- - Necropsy of the surviving animals at 75 mg/kg bw revealed stomach containing dark brown, semifluid material (in one male) and uterus lumen filled with clear fluid (in one female). No abnormalities were noted at other dose levels.
- Necropsy of the dead animals revealed brown stained perineum. - Other findings:
- None
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 for arsenic acid is in the range of 50-200 mg/kg bw in mice therefore it is classified as ‘T; R25 Toxic if swallowed’ according to the Annex VI of the Directive 67/548/EEC and ‘category 3’ according to the CLP Regulation (EC) No. 1272/2008.
- Executive summary:
In an acute oral toxicity study performed similarly to OECD guideline 401 and in compliance with GLP, groups of Crl:CD-1 (ICR) BR mice (5/sex/dose) were given a single oral dose of arsenic acid (75% w/w) at 75, 100 or 200 mg/kg bw. Animals were then observed for mortality, clinical signs and bodyweights for 14 days and were all macroscopically necropsied after death or sacrifice. A preliminary range-finding test was also conducted on 1 mice/sex/dose at four dose levels.
Mortalities were 0, 20 and 70% at 75, 100 and 200 mg/kg bw, respectively. All animals showed expected gain in bodyweight over the study period. Clinical signs noted were diarrhoea, hypoactivity, ataxia and tremors which resolved completely by Day 4 in surviving animals. Necropsy of the surviving animals at 75 mg/kg bw revealed stomach containing dark brown, semifluid material (in one male) and uterus lumen filled with clear fluid (in one female). Necropsy of the dead animals revealed brown stained perineum.
Oral LD50 Combined = 149.6 mg/kg bw (114.4 - 195.5)
Oral LD50 Males = 141.4 mg/kg bw (98.8-202.3)
Oral LD50 Females =160.4 mg kg bw(107.1-240.3)
The oral LD50 for arsenic acid (75% w/w) is in the range of 50-200 mg/kg bw in mice therefore it is classified as ‘T; R25 Toxic if swallowed’ according to the Annex VI of the Directive 67/548/EEC and ‘category 3’ according to the CLP Regulation (EC) No. 1272/2008.
This study is acceptable and satisfies the guideline requirement for an acute oral study (OECD 401) in mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
